Skip to main content

Opioid Use clinical trials at UCSF

6 in progress, 4 open to eligible people

Opioid use includes taking pain-relieving drugs that may lead to addiction. UCSF is comparing injectable and oral buprenorphine for treating opioid use disorder. Another trial tests naltrexone's ability to prevent fentanyl overdoses. UCSF is also examining retention in treatment by comparing office-based methadone with buprenorphine.

Showing trials for
  • Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

    open to eligible people ages 18 years and up

    VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous (in the belly area) formulation of buprenorphine at a target dose of 300mg is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence…

    San Francisco, California and other locations

  • Naltrexone for Overdose Prevention

    open to eligible people ages 18 years and up

    The goal of this clinical trial is to see if an injectable medicine called naltrexone can prevent fentanyl overdose deaths in people who use other drugs (cocaine, methamphetamine). The main questions it aims to answer are: What are the challenges…

    San Francisco, California

  • Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

    open to eligible people ages 18-99

    The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors…

    San Francisco, California and other locations

  • Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department

    open to eligible people ages 18 years and up

    The overarching goal of this proposal is to integrate patient social risk information into an existing electronic health record (EHR)-based clinical decision support (CDS) tool (CDSv1) to facilitate emergency department (ED)-initiated, social…

    San Francisco, California

  • Naloxone for Opioid Associated Out of Hospital Cardiac Arrest

    Sorry, not yet accepting patients

    The investigator's long-term goal is to conduct Naloxone for Opioid Associated out of Hospital Cardiac Arrest (NOPACA), a randomized, double blind, controlled trial to determine the efficacy of naloxone vs. placebo in Opioid Associated out of…

    San Francisco, California

  • Pain and Opioids: Integrated Treatment In Veterans

    Sorry, in progress, not accepting new patients

    This trial will recruit veterans with chronic pain (N = 160) who are prescribed buprenorphine for the treatment of opioid use disorder (OUD). We seek to: (1) examine the efficacy of an integrated treatment to reduce pain interference (Acceptance and …

    San Francisco, California and other locations

Our lead scientists for Opioid Use research studies include .

Last updated: